Grand Pharmaceutical Group Limited announced on 30 April 2026 that its latest Annual Report and accompanying Circular are now available in both English and Chinese on the company website (www.grandpharm.com) and the HKEXnews portal (www.hkexnews.hk). Printed copies will continue to be supplied free of charge upon request to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited.

Aligning with the paperless listing regime that took effect on 31 December 2023, the board confirmed adoption of electronic dissemination for all future corporate communications. Shareholders who prefer hard-copy documents can indicate this by returning the enclosed reply form or emailing grandpharma.ecom@computershare.com.hk.

Non-registered shareholders are urged to provide a functional email address to their custodial intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited—to ensure receipt of electronic notifications. Without a valid email on record, investors will need to monitor the company and HKEXnews websites proactively for new releases.

Enquiries can be directed to Computershare’s hotline on +852 2862 8688 during business hours. The notice is issued under the authority of Chairman Dr Tang Weikun on behalf of Grand Pharmaceutical Group’s board of directors.